Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, drugstore and pharmacy benefits giant CVS Caremark (NYS: CVS) has earned a respected four-star ranking.
With that in mind, let's take a closer look at CVS Caremark and see what CAPS investors are saying about the stock right now.
Woonsocket, R.I. (1892)
CEO Larry Merlo (since March 2011)
Return on Equity (Average, Past 3 Years)
$2.2 billion / $11.1 billion
Sources: Capital IQ (a division of Standard & Poor's) and Motley Fool CAPS.
Late last month, headyinvestor tapped CVS as a relatively strong way to get into the drug store business:
Clearly a better operation than Rite-Aid and Walgreens. Better financials, better stores, broader revenue base (Caremark business). Pharma is going the way of generics and CVS will be there to cater to them. Amazing financials.
Over the past five years, in fact, CVS has grown its top line at a brisk rate of 21% annually. That's much faster than rivals Rite Aid (8%), Walgreen (9%), and Wal-Mart (5.5%).
CAPS member seekingyield elaborates on the bull case:
CVS is currently running a very good retail operation, and a not so good PBM business since its takeover of Caremark a few years ago. This marriage has not yet worked out as management had envisioned, however, there is at least potential that this relationship smoothes out and the PBM and retail businesses begin firing at the same rate. There is a logical fit between these businesses and a turnaround in PBM should result in significant outperformance by the stock as CVS currently trades well below the valuation of peers.
What do you think about CVS, or any other stock for that matter? If you want to retire rich, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future, and on Motley Fool CAPS, thousands of investors are working every day to find them. CAPS is 100% free, so get started!
Interested in another easy way to track CVS Caremark?Add it to your watchlist.
At the time thisarticle was published Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Motley Fool newsletter services have recommended buying shares of and creating a diagonal call position in Wal-Mart. The Fool owns shares of Wal-Mart. Try any of our Foolish newsletter services free for 30 days.We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Fool's disclosure policy always gets a perfect score.
Copyright © 1995 - 2011 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.